Operating Lease, Right-of-Use Asset of REGENERON PHARMACEUTICALS, INC. from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
REGENERON PHARMACEUTICALS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 31 Dec 2024.
  • REGENERON PHARMACEUTICALS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $217,400,000, a 179% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

REGENERON PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $217,400,000 +$139,400,000 +179% 31 Dec 2024 10-K 05 Feb 2025 2024 FY
Q4 2023 $78,000,000 +$6,800,000 +9.6% 31 Dec 2023 10-K 05 Feb 2025 2024 FY
Q4 2022 $71,200,000 31 Dec 2022 10-K 05 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.